Loading...

Kiniksa Pharmaceuticals, Ltd.

KNSANASDAQ
Healthcare
Biotechnology
$33.04
$-0.71(-2.10%)

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Overview

Explore Kiniksa Pharmaceuticals, Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.9/100

Key Financials

Market Cap2.4B
P/E Ratio509.58
EPS (TTM)$0.05
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$30.95
1 Month$30.27
3 Months$26.08
1 Year Target$28.01

KNSA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kiniksa Pharmaceuticals, Ltd. (KNSA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 509.58 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.28%
5-Day Change
-9.02%
1-Month Change
-10.59%
3-Month Change
-6.42%
6-Month Change
-26.83%
Year-to-Date (YTD) Change
-6.47%
1-Year Change
6.88%
3-Year Change
72.37%
5-Year Change
9.001%
All-Time (Max) Change
-4.21%

Contact Information

7814399100
Clarendon House, Hamilton, HM 11

Company Facts

315 Employees
IPO DateMay 25, 2018
CountryBM
Actively Trading

Frequently Asked Questions

;